These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19329226)

  • 1. PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease.
    Rosen RF; Walker LC; Levine H
    Neurobiol Aging; 2011 Feb; 32(2):223-34. PubMed ID: 19329226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease.
    Rosen RF; Ciliax BJ; Wingo TS; Gearing M; Dooyema J; Lah JJ; Ghiso JA; LeVine H; Walker LC
    Acta Neuropathol; 2010 Feb; 119(2):221-33. PubMed ID: 19690877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.
    Ikonomovic MD; Klunk WE; Abrahamson EE; Mathis CA; Price JC; Tsopelas ND; Lopresti BJ; Ziolko S; Bi W; Paljug WR; Debnath ML; Hope CE; Isanski BA; Hamilton RL; DeKosky ST
    Brain; 2008 Jun; 131(Pt 6):1630-45. PubMed ID: 18339640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A distinct subfraction of Aβ is responsible for the high-affinity Pittsburgh compound B-binding site in Alzheimer's disease brain.
    Matveev SV; Spielmann HP; Metts BM; Chen J; Onono F; Zhu H; Scheff SW; Walker LC; LeVine H
    J Neurochem; 2014 Nov; 131(3):356-68. PubMed ID: 24995708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.
    Klunk WE; Lopresti BJ; Ikonomovic MD; Lefterov IM; Koldamova RP; Abrahamson EE; Debnath ML; Holt DP; Huang GF; Shao L; DeKosky ST; Price JC; Mathis CA
    J Neurosci; 2005 Nov; 25(46):10598-606. PubMed ID: 16291932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue.
    Ni R; Gillberg PG; Bergfors A; Marutle A; Nordberg A
    Brain; 2013 Jul; 136(Pt 7):2217-27. PubMed ID: 23757761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Clickable Pittsburgh Compound B for the Detection and Capture of β-Amyloid in Alzheimer's Disease Brain.
    Diner I; Dooyema J; Gearing M; Walker LC; Seyfried NT
    Bioconjug Chem; 2017 Oct; 28(10):2627-2637. PubMed ID: 28862836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmortem Pittsburgh Compound B (PiB) binding increases with Alzheimer's disease progression.
    Beckett TL; Webb RL; Niedowicz DM; Holler CJ; Matveev S; Baig I; LeVine H; Keller JN; Murphy MP
    J Alzheimers Dis; 2012; 32(1):127-38. PubMed ID: 22766739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Effects of Structural Modifications on the Competition of Chalcones for the PIB Amyloid Imaging Ligand-Binding Site in Alzheimer's Disease Brain and Synthetic Aβ Fibrils.
    Fosso MY; McCarty K; Head E; Garneau-Tsodikova S; LeVine H
    ACS Chem Neurosci; 2016 Feb; 7(2):171-6. PubMed ID: 26682772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization of brain amyloid and microglial activation in mouse models of Alzheimer's disease.
    Higuchi M
    Curr Alzheimer Res; 2009 Apr; 6(2):137-43. PubMed ID: 19355848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis.
    Lockhart A; Lamb JR; Osredkar T; Sue LI; Joyce JN; Ye L; Libri V; Leppert D; Beach TG
    Brain; 2007 Oct; 130(Pt 10):2607-15. PubMed ID: 17698496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.
    Johnson AE; Jeppsson F; Sandell J; Wensbo D; Neelissen JA; Juréus A; Ström P; Norman H; Farde L; Svensson SP
    J Neurochem; 2009 Mar; 108(5):1177-86. PubMed ID: 19141073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease.
    Rosen RF; Tomidokoro Y; Farberg AS; Dooyema J; Ciliax B; Preuss TM; Neubert TA; Ghiso JA; LeVine H; Walker LC
    Neurobiol Aging; 2016 Aug; 44():185-196. PubMed ID: 27318146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between biomarkers in aging and dementia.
    Jagust WJ; Landau SM; Shaw LM; Trojanowski JQ; Koeppe RA; Reiman EM; Foster NL; Petersen RC; Weiner MW; Price JC; Mathis CA;
    Neurology; 2009 Oct; 73(15):1193-9. PubMed ID: 19822868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid β accumulation assessed with ¹¹C-Pittsburgh compound B PET and postmortem neuropathology.
    Hatsuta H; Takao M; Ishii K; Ishiwata K; Saito Y; Kanemaru K; Arai T; Suhara T; Shimada H; Shinotoh H; Tamaoka A; Murayama S
    Curr Alzheimer Res; 2015; 12(3):278-86. PubMed ID: 25731622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid.
    Grimmer T; Riemenschneider M; Förstl H; Henriksen G; Klunk WE; Mathis CA; Shiga T; Wester HJ; Kurz A; Drzezga A
    Biol Psychiatry; 2009 Jun; 65(11):927-34. PubMed ID: 19268916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.
    Fodero-Tavoletti MT; Smith DP; McLean CA; Adlard PA; Barnham KJ; Foster LE; Leone L; Perez K; Cortés M; Culvenor JG; Li QX; Laughton KM; Rowe CC; Masters CL; Cappai R; Villemagne VL
    J Neurosci; 2007 Sep; 27(39):10365-71. PubMed ID: 17898208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease.
    Fagan AM; Mintun MA; Shah AR; Aldea P; Roe CM; Mach RH; Marcus D; Morris JC; Holtzman DM
    EMBO Mol Med; 2009 Nov; 1(8-9):371-80. PubMed ID: 20049742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anionic Oligothiophenes Compete for Binding of X-34 but not PIB to Recombinant Aβ Amyloid Fibrils and Alzheimer's Disease Brain-Derived Aβ.
    Bäck M; Appelqvist H; LeVine H; Nilsson KP
    Chemistry; 2016 Dec; 22(51):18335-18338. PubMed ID: 27767229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients.
    Svedberg MM; Hall H; Hellström-Lindahl E; Estrada S; Guan Z; Nordberg A; Långström B
    Neurochem Int; 2009; 54(5-6):347-57. PubMed ID: 19162107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.